Interestingly, evidence from preclinical models supports a functional link between intestinal bitter taste receptor (BTRs) and gastrointestinal hormone secretion, and the outcomes of recent studies indicate that stimulation of intestinal BTRs may be used to modulate gastrointestinal function, to diminish energy intake and limit postprandial blood glucose excursions in humans
This happens because appetite levels return to normal and pre-treatment eating habits often resurface
10.1016/S0893-133X(00)00208-6 24
The more practical question is whether peptides can complement existing therapies and potentially allow reduction of treatments that cause long-term side effects
Supportive secondary endpoints were C max , t max , t 1/2 and CL/F
Modified GRF 1-29, or CJC-1295 without DAC) involves replacing amino acids #2, #8, #15, and #27 in GRF 1-29 to yield an analogue with a half-life of 30 minutes, thereby increasing binding affinity to GHRH receptors while also improving its biological stability (its naming can be traced back to an anonymous researcher known as DatBtrue who coined the term in 2008)